Barlow Wealth Partners Inc. Buys New Shares in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Barlow Wealth Partners Inc. purchased a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the fourth quarter, HoldingsChannel reports. The fund purchased 11,668 shares of the company’s stock, valued at approximately $100,000.

Several other large investors have also added to or reduced their stakes in the company. Teza Capital Management LLC acquired a new stake in shares of Alignment Healthcare during the third quarter worth about $109,000. Panagora Asset Management Inc. increased its stake in shares of Alignment Healthcare by 16.8% in the third quarter. Panagora Asset Management Inc. now owns 345,798 shares of the company’s stock worth $2,400,000 after acquiring an additional 49,716 shares during the period. Los Angeles Capital Management LLC purchased a new position in shares of Alignment Healthcare during the third quarter worth $641,000. Mackenzie Financial Corp lifted its position in Alignment Healthcare by 38.1% during the third quarter. Mackenzie Financial Corp now owns 31,069 shares of the company’s stock valued at $218,000 after purchasing an additional 8,577 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in Alignment Healthcare by 9.4% in the third quarter. Assenagon Asset Management S.A. now owns 543,197 shares of the company’s stock valued at $3,770,000 after purchasing an additional 46,747 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Insiders Place Their Bets

In other news, CEO John E. Kao acquired 103,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average cost of $4.82 per share, with a total value of $496,460.00. Following the purchase, the chief executive officer now owns 2,745,253 shares in the company, valued at $13,232,119.46. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CFO Robert Thomas Freeman sold 11,858 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the completion of the sale, the chief financial officer now owns 898,228 shares of the company’s stock, valued at approximately $4,392,334.92. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO John E. Kao bought 103,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was acquired at an average cost of $4.82 per share, for a total transaction of $496,460.00. Following the completion of the purchase, the chief executive officer now directly owns 2,745,253 shares in the company, valued at $13,232,119.46. The disclosure for this purchase can be found here. In the last three months, insiders sold 90,213 shares of company stock worth $460,587. Corporate insiders own 6.30% of the company’s stock.

Alignment Healthcare Price Performance

NASDAQ ALHC traded up $0.09 on Tuesday, hitting $6.87. The company had a trading volume of 1,312,347 shares, compared to its average volume of 912,560. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. The company’s fifty day moving average price is $5.13 and its 200-day moving average price is $6.52. The company has a market capitalization of $1.31 billion, a PE ratio of -8.18 and a beta of 1.23. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $9.20.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, May 2nd. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.01). Alignment Healthcare had a negative net margin of 7.81% and a negative return on equity of 91.06%. The company had revenue of $628.60 million during the quarter, compared to analyst estimates of $599.75 million. During the same quarter last year, the business earned ($0.20) EPS. The firm’s revenue for the quarter was up 43.1% compared to the same quarter last year. As a group, analysts predict that Alignment Healthcare, Inc. will post -0.6 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on ALHC shares. UBS Group reduced their price objective on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating for the company in a research note on Wednesday, February 28th. Stephens boosted their price target on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a report on Friday. Stifel Nicolaus dropped their price objective on shares of Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, April 23rd. Barclays started coverage on shares of Alignment Healthcare in a research note on Wednesday, March 6th. They issued an “underweight” rating and a $4.50 target price for the company. Finally, William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $8.47.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.